First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

Por Painter, Wendy, Robertson, Alice, Trost, Lawrence C., Godkin, Susan, Lampert, Bernhard, Painter, George
Publicado em 2012

In Vitro Efficacy of Brincidofovir against Variola Virus

Por Olson, Victoria A., Smith, Scott K., Foster, Scott, Li, Yu, Lanier, E. Randall, Gates, Irina, Trost, Lawrence C., Damon, Inger K.
Publicado em 2014

Postchallenge Administration of Brincidofovir Protects Healthy and Immune-Deficient Mice Reconstituted with Limited Numbers of T Cells from Lethal Challenge with IHD-J-Luc Vaccinia...

Por Zaitseva, Marina, McCullough, Kevin Tyler, Cruz, Stephanie, Thomas, Antonia, Diaz, Claudia G., Keilholz, Laurie, Grossi, Irma M., Trost, Lawrence C., Golding, Hana
Publicado no J Virol (2015)

Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infection...

Por Painter, George R., Almond, Merrick R., Trost, Lawrence C., Lampert, Bernhard M., Neyts, Johan, De Clercq, Erik, Korba, Brent E., Aldern, Kathy A., Beadle, James R., Hostetler, Karl Y.
Publicado em 2007

Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections

Por Painter, George R., Almond, Merrick R., Trost, Lawrence C., Lampert, Bernhard M., Neyts, Johan, De Clercq, Erik, Korba, Brent E., Aldern, Kathy A., Beadle, James R., Hostetler, Karl Y.
Publicado em 2007